UBS Group AG - PARDES BIOSCIENCES INC ownership

PARDES BIOSCIENCES INC's ticker is and the CUSIP is 69945Q105. A total of 68 filers reported holding PARDES BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PARDES BIOSCIENCES INC
ValueSharesWeighting
Q2 2023$614
-95.9%
339
-97.0%
0.00%
Q1 2023$14,924
-45.6%
11,306
-30.3%
0.00%
Q4 2022$27,424
-45.2%
16,227
-40.4%
0.00%
Q3 2022$50,000
-30.6%
27,240
+15.1%
0.00%
Q2 2022$72,000
+7100.0%
23,664
+15676.0%
0.00%
Q1 2022$1,000
-50.0%
1500.0%0.00%
Q4 2021$2,0001500.00%
Other shareholders
PARDES BIOSCIENCES INC shareholders Q3 2022
NameSharesValueWeighting ↓
Foresite Capital Opportunity Management V, LLC 5,227,307$16,048,00040.44%
Foresite Capital Management V, LLC 9,400,515$28,860,00020.16%
Lynx1 Capital Management LP 2,180,560$6,694,0005.70%
VK Services, LLC 6,151,766$18,886,0002.82%
Arena Capital Advisors, LLC- CA 851,281$2,613,0000.66%
RA Capital Management 6,175,038$18,957,0000.50%
DAFNA Capital Management LLC 451,105$1,385,0000.38%
Sio Capital Management, LLC 315,564$969,0000.36%
Chescapmanager LLC 361,716$1,110,0000.26%
Frazier Life Sciences Management, L.P. 845,636$2,596,0000.24%
View complete list of PARDES BIOSCIENCES INC shareholders